Journal Article

Risk factors and the resistance mechanisms involved in Pseudomonas aeruginosa mutation in critically ill patients

Ruiz, Stéphanie, Minville, Vincent, Fourcade, Olivier, Vardon-Bounes, Fanny, Druge, Stéphanie, Conil, Jean-Marie, Labaste, François, Seguin, Thierry, Grare, Marion, Georges, Bernard

2019

Overview

Background The objective of this study was to determine the main risk factors of Pseudomonas aeruginosa mutation as well as the mechanisms of acquired resistance. Methods We conducted a 2-year prospective study in patients who were carriers of a Pseudomonas aeruginosa strain and who had been admitted to a medical/surgical ICU. Results Of the 153 patients who were included, 34 had a mutation in their strain. In a multivariate analysis, a duration of ventilation > 24 days was a risk factor for mutation (risk ratio 4.29; CI 95% 1.94–9.49) while initial resistance was a protective factor (RR 0.36; CI 95% 0.18–0.71). In a univariate analysis, exposure of P. aeruginosa to ceftazidime was associated with an over-production of AmpC cephalosporinase and exposure to meropenem was associated with impermeability. A segmentation method based on the duration of ventilation (> 24 days), initial resistance, and exposure of strains to ceftazidime made it possible to predict at 83% the occurrence of mutation. Conclusion The duration of ventilation and the presence of resistance as soon as P. aeruginosa is identified are predictive factors of mutation in ICU patients.

• Publisher: BioMed Central,BioMed Central Ltd,BMC
• Subject: Antibiotic / Beta lactamases / Care and treatment / Cefepime / Cloxacillin / Critical Care Medicine / Critically ill persons / EDTA / Gene mutation / Genetic aspects / Health aspects / ICU (intensive care unit) / Imipenem / Intensive / Medical research / Medicine / Medicine & Public Health / Microbial drug resistance / Mutation / Pseudomonas aeruginosa / Pseudomonas aeruginosa infections / Resistance mechanism / Risk factors / Segmentation tree